Breast Neoplasms, Male
Showing 1 - 25 of >10,000
Male Breast Cancer Patients at Methodist Health System
Recruiting
- Male Breast Cancer Patients
- managing Male Breast Cancer Patients at Methodist Health System
-
Dallas, Texas
- +1 more
Nov 13, 2023
Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston
Not yet recruiting
- Male Breast Cancer
- +2 more
- Tamoxifen
- +3 more
-
Boston, Massachusetts
- +1 more
Aug 12, 2022
Breast - Female, Male Breast Cancer Trial in Charlotte (Pembrolizumab, Paclitaxel)
Completed
- Breast - Female
- Male Breast Cancer
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 25, 2023
Finasteride and Male Breast Cancer - A Register-Based Nested
Completed
- Male Breast Cancer
- (no location specified)
Feb 7, 2022
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)
Recruiting
- Breast Cancer
- +7 more
- Dendritic Cell Vaccine (DC1)
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022
Treating Patients With Stage IV Breast Cancer
Active, not recruiting
- Central Nervous System Metastases
- +15 more
- hyperfractionated radiation therapy
- +2 more
-
North Chicago, IllinoisUniversity of Chicago
Dec 6, 2021
Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)
Recruiting
- Breast Cancer Female
- +7 more
- DC1 Vaccine
- WOKVAC Vaccine
-
Tampa, Florida
- +6 more
Apr 4, 2022
Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)
Completed
- Metastatic Breast Cancer
- Metastatic Gastric Cancer
- Trastuzumab for injection
- Herceptin
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023
Breast Cancer Trial in Berlin (420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection, Perjeta (EU origin) 420 mg in 14 mL
Recruiting
- Breast Cancer
- 420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection
- +2 more
-
Berlin, GermanyCRS Clinical Research Services Berlin GmbH
Jul 20, 2022
Progress of Breast Cancer Cases in Males and Assessment of
Recruiting
- Breast Cancer, Male
-
Ferrol, A Coruña, Spain
- +53 more
Jul 19, 2022
Malignant Tumor of Breast, Malignant Tumors of Digestive Organs, Malignant Tumors of Female Genital Organs Trial in Houston
Recruiting
- Malignant Neoplasm of Breast
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 29, 2021
Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)
Active, not recruiting
- Advanced Malignant Neoplasm
- +38 more
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)
Completed
- Prostate Cancer
- enzalutamide
- +3 more
-
Chisinau, Moldova, Republic ofSite MD37301
Jan 14, 2022
Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)
Completed
- Breast Cancer
- +2 more
- Tamoxifen
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022
Breast Cancer, Breast Cancer, Female, Breast Cancer, Male Trial in Tampa (Fluoro-D-glucose-positron Emission Tomography,
Withdrawn
- Breast Cancer
- +3 more
- Fluoro-D-glucose-positron Emission Tomography
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Dec 3, 2020
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast
Active, not recruiting
- HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
- PF-06873600
- +2 more
-
Birmingham, Alabama
- +54 more
Nov 21, 2022
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Breast Cancer Trial in Worldwide
Active, not recruiting
- Breast Cancer
-
Birmingham, Alabama
- +92 more
Jul 27, 2021
Pattern of Clinical Presentation of Different Breast Disease in
Completed
- Breast Disease
- +3 more
-
Dharan, Province 1, NepalBPKIHS
Sep 4, 2023
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of
Not yet recruiting
- Organoids
- +2 more
- Biopsy
- (no location specified)
Nov 24, 2023
Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)
Not yet recruiting
- Metastatic Triple-Negative Breast Cancer
- Trilaciclib
- +3 more
-
Charlotte, North CarolinaLevine Cancer Institute
Aug 31, 2023